The chromosome complement was assessed in Merino sheep embryos collected at 3 and 5 days after the onset of oestrus. Donor ewe treatments were: untreated, or immunized against androstenedione (day 3); and untreated, or treated with follicle-stimulating hormone (FSH), or treated with FSH plus immunization against androstenedione (day 5). No significant differences in the frequency of chromosomally abnormal embryos between treatment groups within each age group were observed, so the data have been combined.
Introduction
The presence of cytogenetic abnormalities in cleavage-stage embryos has been correlated with early embryonic mortality in mammals. Considerable data now exist for man (Chandley 1981) and laboratory animals (see review table in Binkert and Schmid 1977) , but the number of studies on chromosome abnormalities in embryos of livestock species is quite small.
Analysis must be carried out on cleavage stage embryos to obtain an accurate assessment of the frequency of chromosomally abnormal embryos, as unbalanced embryos are usually lost before reaching the blastocyst-elongation or egg-cylinder stage (Murray et al. 1986a) . However, the time of loss of aberrant embryos between day 3 and day 13 is not known. There are no data available on the frequency of chromosome abnormalities in cleavage-stage embryos from pigs, and the data available for cattle are confounded by the use of exogenous hormones to produce superovulation (King et al. 1981; Gayerie de Abreu et al. 1984; Murray et al. 1985b) . The possible effects of superovulation on the incidence of cytogenetically unbalanced embryos is not clear, as conflicting evidence has been published from both livestock and laboratory species (see Murray et al. 1986b) .
The incidence of chromosome abnormalities in cleavage-stage sheep embryos has been estimated to be 60/0 (Long and Williams 1980) and 11 % (Murray et al. 1985a) , with the frequency dropping to 1·9% in day 13-14 blastocysts (Murray et al. 1986a ). Long and Williams (1980) principally observed aneuploid abnormalities (5/6), whereas in the study by Murray et al. (1985a) 7 of the 8 abnormalities in early embryos were of the euploid type involving entire chromosome sets.
The present paper reports results of the chromosomal analysis of 37 Merino embryos collected on day 3 following oestrus in untreated and androstenedione-immune ewes and from 40 day-5 embryos collected from ewes treated with follicle-stimulating hormone (FSH) with or without immunization against androstenedione. Embryos enter the tip of the uterine horn between day 4 and day 5; the day-5 embryos were therefore analysed to assess whether the time of loss of chromosomally abnormal embryos coincided with the movement of the embryos into the uterus.
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Materials and Methods
Embryos for this study were collected from ewes being used in two unrelated experiments, the first studying embryo mortality and the second studying methods for increasing ovulation rate. In both experiments, ewes were syncronized in the previous oestrous cycle using progestagen-impregnated sponges (Repromap, Upjohn Pty Ltd, Rydalmere, N. S. W.) and left untreated or immunized against androstenedione-7-human serum albumin (Fecundin, Glaxo Animal Health Pty Ltd, Boronia, Vic.). Two injections of Fecundin were given, with the booster injection timed such that it was given 21 days after the primary injection and 14 days before expected mating. Ewes were exposed to two relays of harnessed Merino rams (1 ram per 15 ewes), which were alternated at the morning and evening checks for oestrus. All day-3 embryos were collected from ewes either left untreated or given these treatments and two day-5 embryos were collected from untreated ewes.
In the second experiment, the protocol was altered by the addition of a superovulatory treatment. Starting 24 h before sponge removal, ewes were given four injections at 12-h intervals of 6, 5, 3 and 2 mg equivalents (Armour units), respectively, of FSH (gift from Y. Combarnous, Nouzilly, France) to give a total dose of 15 mg Armour equivalents of FSH. The donors of most of the day-5 embryos were ewes which had been treated with FSH, or with FHS plus immunization against androstenedione.
Embryos were collected at either 48-60 h (day 3; 1-4 cell) or 108-120 h (day 5; 16-64 cell) after mating by surgically flushing the top of the uterine horn and oviducts with 3-4 ml phosphate-buffered saline (PBS; O·IM, pH 7 ·8) containing 50/0 heat-inactivated sheep serum. Embryos were cultured in PBS containing 15% sheep serum, 0·8 JLg colchicine ml-1, 100 i.u. penicillin G ml-1 and 100 JLg streptomycin sulfate ml-1 for 10 h at 37°C with a 5% CO2 in air atmosphere before preparation of chromosomes by the method of Long and Williams (1978) . Embryos were individually transferred to clean slides and the excess hypotonic solution removed. One drop of methanol:acetic acid fixative (1:1, v/v) was dropped onto the embryo from a height of 27 cm. Chromosome preparations were stained in 5% Giemsa in 0·004 M phosphate buffer for 3·5 min, air-dried and mounted in DPX.
Results
Chromosome counts were accurately obtained from 37 of the 106 day-3 embryos processed (Table 1) . There was no significant difference with respect to the incidence of chromosome abnormalities between the untreated or immunized groups and therefore the data have been pooled. Three embryos had ::: 54 chromosomes, but a complete count was not possible because of overlapping chromosomes. The frequency of day-3 embryos with euploid abnormalities is 4 out of 37 or 10·8% (Table 1 ). The two 5n embryos were from the same ewe. The 5n embryos were males as both contained Y chromosomes. A 5n cell is illustrated in the composite photograph in Fig. 1 . There was no significant difference between the FSH only and the FSH-plus-immunization groups with respect to the frequency of day-5 embryos with abnormal chromosome complements, so the data have been combined. The two embryos from untreated ewes have also been included in the total even though they were both abnormal. The 3n embryo was a male, while the In/2n mosaics lacked a Y chromosome in both the In and the 2n cells. The incidence of day-5 embryos with euploid abnormalities is thus 15·4070 (4/26), or, if near-diploids are included,
Discussion
The overall frequency of day-3 embryos observed in this study with euploid chromosome abnormalities was 10·80/0. This result is not significantly different from the 11% abnormalities a 5n cell from a 3-cell embryo.
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• • observed in an earlier study (Murray et al. 1985a) . By combining the two data sets, the estimated frequency of chromosomally abnormal day-3 embryos in Merino sheep becomes 11·2% (12/107). The estimated frequency of chromosomally aberrant embryos in Merino sheep does not differ from the 6% incidence of abnormal embryos reported by Long and Williams (1980) in British breeds. The frequency of abnormal embryos at day 5 was 15·4%, all observed abnormalities being of the euploid type. When near-diploid embryos were included, the frequency of abnormal embryos dropped to 10·0%. The incidence of euploid aberrant embryos observed here does not differ from the 6·25% (3/48) abnormal rate observed in embryos collected from Merino ewes superovulated with pregnant mare serum gonadotrophin (PMSG) (Murray et al. 1986a) .
The frequency of chromosomally aberrant embryos did not significantly drop between the day-3 and day-5 groups in this study (11,8% and 15·4%, respectively) ; this indicates that the unbalanced chromosomal state of the abnormal embryos is not lethal until some time after the embryos have entered the uterine horn. Most of the abnormal embryos are lost by day 13 of development in the Merino, as Murray et al. (1986b) observed chromosome abnormalities in only 1·9% of the elongated blastocysts examined. This is also consistent with other work where the incidence of chromosome abnormalities was very low in blastocysts of sheep (Long 1977) and cattle (Hare et af. 1980) .
The majority (18/19) of chromosome abnormalities observed in early Merino embryos in this and our previous studies (Murray et af. 1985a (Murray et af. , 1986b were of the euploid or fertilizationerror type. Embryos with aneuploid abnormalities, arising from meiotic non-disjunction, may be confused with hypo-or hyperdiploid chromosome spreads produced by the fixation technique and may thus not be detected. A single hyperdiploid embryo (2n = 55) was identified in our previous study (Murray et af. 1985a) . Thus, assuming hypo-and hyperdiploidy occur at the same frequency, approximately 10070 of the chromosomally abnormal cleavage-stage Merino embryos are of the aneuploid type. ' The 18 Merino embryos thus far identified in this and in our previous studies as having euploid abnormalities have been four In, eight Inl2n, three 3n, one 4n and two 5n (Murray et af. 1985a (Murray et af. , 1986b . Murray et af. (1985a) presented evidence that the single 4n embryo and three of the Inl2n mosaic embryos originated by polyspermy, as, in the latter case, the In cells contained Y chromosomes. In the present study, one of the 3n embryos and both of the 5n embryos had two Y chromosomes. Polyspermy is therefore the major, if not the only, cause of haploid/diploid mosaicism and polyploidy in cleavage-stage Merino embryos. The origin of the four haploid embryos is still unclear, as none contained a Y chromosome and a 27-X complement is consistent with either a parthenogenetic or androgenetic origin.
Haploid and polyploid embryos are lost by day 13 of development in the Merino (Murray et af. 1986a) . The fate of the Inl2n mosaic embryos is, however, unclear. In recent work in mice, androgenetic and normal diploid embryos were combined and normal young were produced with no detectable androgenetic cells (Surani et af. 1986 ). This indicates that the In cells derived by polyspermy may be lost from the Inl2n embryos without affecting the normal development of the diploid cells.
